News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Carl E. Allen was elected as Chair of the SIOP PARC Programme
Photo from SIOP/LinkedIn
Jul 3, 2024, 08:21

Carl E. Allen was elected as Chair of the SIOP PARC Programme

The International Society of Paediatric Oncology (SIOP) shared on LinkedIn:

“Congratulations to Professor Carl E. Allen (US) on being elected Chair of the SIOP PARC Programme!

More about the SIOP PARC Programme here.”

Source: SIOP/LinkedIn

cancer Carl E. Allen International Society of Paediatric Oncology OncoDaily Oncology SIOP SIOP PARC Programme
Insight
Jul 5, 2024, 15:41
Development of an EORTC QoL module for patients with advanced melanoma
Blog
Jul 5, 2024, 15:32
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Drugs
Jul 5, 2024, 15:03
Andrea Apolo: Phase 1 study of Cabozantinib, Nivolumab, and Ipilimumab for genitourinary tumours
Insight
Jul 5, 2024, 14:55
Insurance Coverage for Next Generation Sequencing and Closing Points - GRACE
Insight
Jul 5, 2024, 14:45
Maria Babak: Must read on CAR T-Cell Therapy
Insight
Jul 5, 2024, 14:28
Launch of our Last Mile program for breast cancer patients in Nepal - The Max Foundation
Insight
Jul 5, 2024, 14:21
Rugengamanzi Eulade: Hodgkin’s Lymphoma in Tanzania according to HIV status during the HAART era
Blog
Jul 5, 2024, 14:17
Whijae Roh: The history of chromosomal instability in genome doubled tumors
Insight
Jul 5, 2024, 14:13
White Paper on crucial need for Equity, Diversity, and Inclusion (EDI) in cancer care - Youth Cancer Europe
Blog
Jul 5, 2024, 14:10
Challenges in utilizing mutation testing in AML - The Video Journal of Hematology and Hematological Oncology
Insight
Jul 5, 2024, 13:47
Andrea Apolo: Very proud of this Clinical Trial of Cabozantinib/Nivolumab published at JCO
Insight
Jul 5, 2024, 13:43
Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth